Evaluate the Pharmacokinetic Interaction and the Safety of AD-2321 and AD-2322
Evaluate the Pharmacokinetic Interaction and the Safety of AD-2321 and AD-2322
Not yet recruiting · NCT07312799 · Registry updated 2025-12-31Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| Evaluate the Pharmacokinetic Interaction and the Safety of AD-2321 and AD-2322 | cardiovascular disorder, hypertensive disorder, vascular disorder | Not yet recruiting | Phase 1 | 2025-12-31 | NCT07312799 |
1 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Addpharma Inc. | 24 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| H+ Yangji Hospital | Seoul | South Korea | 2 |